US Broker Ratings

Praxis Precision Medicines, Inc (PRAX) Stock Analysis: Exploring a 63% Upside in the Biotech Sector

Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a burgeoning entity in the healthcare sector, specifically the biotechnology industry, is attracting significant investor interest with its innovative approach..

Personalis, Inc. (PSNL) Stock Analysis: A 11.76% Potential Upside Amidst Revenue Challenges

Personalis, Inc. (NASDAQ: PSNL), a prominent player in the healthcare sector, specializing in diagnostics and research, finds itself at a pivotal juncture. As the company grapples..

Arvinas, Inc. (ARVN) Stock Analysis: Unveiling Insights into Its Biotech Potential

Arvinas, Inc. (NASDAQ: ARVN) stands as a promising player in the biotechnology sector, capturing investor attention with its innovative approach to tackling disease through targeted protein..

Cel-Sci Corporation (CVM): Investor Outlook with Potential 624% Upside

Cel-Sci Corporation (NASDAQ: CVM) presents a compelling case for investors seeking bold opportunities in the healthcare sector. Situated within the burgeoning field of biotechnology, Cel-Sci focuses..

Celcuity Inc. (CELC) Stock Analysis: Navigating High Potential in Biotechnology with a $5.19 Billion Market Cap

Celcuity Inc. (NASDAQ: CELC) is capturing the attention of investors with its promising endeavors in the biotechnology sector. As a clinical-stage company focused on innovative cancer..

Tyra Biosciences, Inc. (TYRA) Stock Analysis: Exploring a Promising 17% Upside Potential in Precision Medicine

Tyra Biosciences, Inc. (NASDAQ: TYRA) is making waves in the biotechnology sector with its innovative approach to precision medicine, particularly in fibroblast growth factor receptor (FGFR)..

Eton Pharmaceuticals, Inc. (ETON) Stock Analysis: Unraveling the 96.72% Potential Upside for Investors

Eton Pharmaceuticals, Inc. (NASDAQ: ETON), a rising star in the healthcare sector, has been capturing the attention of investors with its robust revenue growth and promising..

Oric Pharmaceuticals, Inc. (ORIC) Stock Analysis: Exploring 95% Upside Potential Amid Biotech Innovation

Oric Pharmaceuticals, Inc. (NASDAQ: ORIC) is making waves in the biotechnology sector with its promising pipeline of cancer-fighting therapies. As a clinical-stage biopharmaceutical company based in..

Abivax SA (ABVX) Investor Outlook: Analysts Project Strong 34.49% Upside Potential

Abivax SA (ABVX), a Paris-based biotechnology firm, is making waves in the healthcare sector with its promising pipeline in the treatment of chronic inflammatory diseases. As..

Maze Therapeutics, Inc. (MAZE): Investor Outlook and 9.88% Potential Upside

Maze Therapeutics, Inc. (NASDAQ: MAZE) has been making waves in the biotechnology sector with its innovative approach to treating complex diseases. Investors are taking notice of..

SIGA Technologies Inc. (SIGA) Stock Analysis: A Deep Dive into Future Growth Potential in the Healthcare Sector

SIGA Technologies Inc. stands out in the healthcare sector as a commercial-stage pharmaceutical company with a focus on the health security market. Headquartered in New York,..

Talkspace, Inc. (TALK) Stock Analysis: A 28% Upside Potential Attracts Investor Attention

Talkspace, Inc. (NASDAQ: TALK) is capturing investor interest with a promising potential upside of 28.21%, as reflected in its current analyst ratings. This virtual behavioral healthcare..

LifeMD, Inc. (LFMD) Stock Analysis: Unveiling a 174% Potential Upside in the Telehealth Sector

LifeMD, Inc. (NASDAQ: LFMD), a burgeoning player in the healthcare industry, offers a compelling investment opportunity in the rapidly expanding telehealth sector. With a market capitalization..

Kamada Ltd. (KMDA) Stock Analysis: Exploring the 55% Potential Upside in the Healthcare Sector

Kamada Ltd. (NASDAQ: KMDA), an Israel-based healthcare company specializing in plasma-derived protein therapeutics, has captured investor attention with a notable potential upside of 55.32%, according to..

Treace Medical Concepts, Inc. (TMCI) Stock Analysis: Exploring a 111.74% Potential Upside in the Healthcare Sector

Treace Medical Concepts, Inc. (NASDAQ: TMCI), a promising player in the medical devices industry, is capturing attention with its innovative approach to addressing common foot deformities...

Maravai LifeSciences Holdings (MRVI): Investor Outlook Amidst a 14.54% Potential Upside

Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI) stands as a pivotal player in the biotechnology sector, offering a diverse range of products that fuel the development of..

Tilray Brands, Inc. (TLRY) Investor Outlook: Potential 55% Upside Amidst Market Challenges

Tilray Brands, Inc. (NASDAQ: TLRY) presents an intriguing case for investors who are keen on exploring opportunities within the healthcare sector, specifically in the burgeoning cannabis..

Myriad Genetics, Inc. (MYGN) Stock Analysis: Exploring a 46.57% Potential Upside Amid Market Volatility

Myriad Genetics, Inc. (NASDAQ: MYGN), a key player in the healthcare sector specializing in diagnostics and research, presents an intriguing case for investors navigating the complex..

Castle Biosciences, Inc. (CSTL) Stock Analysis: Uncovering an 18.93% Potential Upside in the Diagnostics Sector

Castle Biosciences, Inc. (NASDAQ: CSTL) has emerged as a noteworthy player within the healthcare sector, specifically within the diagnostics and research industry. Headquartered in Friendswood, Texas,..

Septerna, Inc. (SEPN) Investor Outlook: 42% Potential Upside Amidst Breakthrough Growth in Revenue

Septerna, Inc. (SEPN), a trailblazer in the biotechnology sector, is capturing investor attention with its impressive growth trajectory and burgeoning market presence. Headquartered in South San..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds